McGill University

Researchers

• EZEduardo R Zimmer
• MWMarcel S Woo
• WFWilliam D Foulkes

Running trials

• Not yet recruiting

  Dialysis Less Frequently in the Elderly

  NCT07738731· Queen's University· Source

• Recruiting

  A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

  NCT07405801· Phase 2· Hoffmann-La Roche· Source

• Recruiting

  Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07491445· Phase 3· Revolution Medicines, Inc.· Source

• Recruiting

  Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

  NCT07154706· Phase 3· Nuvation Bio Inc.· Source

• Active, not recruiting

  A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia

  NCT06953583· Phase 3· Biogen· Source

• Recruiting

  Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada

  NCT07095192· McGill University· Source

• Recruiting

  A Study of Lorigerlimab in Participants With Advanced Solid Tumors

  NCT06730347· Phase 2· MacroGenics· Source

• Recruiting

  Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

  NCT06801834· Phase 3· Gilead Sciences· Source

• Enrolling by invitation

  Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0

  NCT06823115· Indiana University· Source

• Active, not recruiting

  Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML

  NCT06578247· Phase 3· Daiichi Sankyo· Source

• Not yet recruiting

  Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery

  NCT06530524· Phase 2· Sir Mortimer B. Davis - Jewish General Hospital· Source

• Recruiting

  The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes

  NCT07348432· McGill University· Source

• Recruiting

  Fibrosis Lessens After Metabolic Surgery

  NCT06374875· Phase 4· The Cleveland Clinic· Source

• Active, not recruiting

  MagDI Canada Study

  NCT06467955· GT Metabolic Solutions, Inc.· Source

• Active, not recruiting

  [Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer

  NCT06229366· Phase 1· Eli Lilly and Company· Source

• Active, not recruiting

  Cryoablation for Monomorphic Ventricular Tachycardia

  NCT05675865· Adagio Medical· Source

• Recruiting

  Using Micro-filaments to Detect "fast Ripples" and Improve the Identification of the Epileptogenic Zone

  NCT05254730· Adrien Peyrache· Source

• Active, not recruiting

  AMP SCZ® Observational Study: PREDICT-DPACC

  NCT05905003· Brigham and Women's Hospital· Source

• Active, not recruiting

  Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease

  NCT05361382· Phase 1· Tharick Pascoal· Source

• Recruiting

  Parkinson's Foundation PD GENEration Genetic Registry

  NCT04994015· Parkinson's Foundation· Source

• Recruiting

  Evaluating Oral Peri-operative Acetylsalicylic Acid in Subjects Undergoing Endovascular Coiling-only of Unruptured Brain Aneurysms

  NCT04192955· Phase 3· University of Calgary· Source

• Recruiting

  PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  NCT04477785· Michael J. Fox Foundation for Parkinson's Research· Source

• Active, not recruiting

  SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

  NCT03546582· Phase 2· RTOG Foundation, Inc.· Source

• Recruiting

  International Severe Asthma Registry: Canadian Cohort

  NCT04045587· University of British Columbia· Source

• Recruiting

  Quebec Low Back Pain Study: Core Dataset

  NCT04791891· Laval University· Source

• Enrolling by invitation

  North American Prodromal Synucleinopathy Consortium

  NCT03623672· Washington University School of Medicine· Source

• Active, not recruiting

  Staged Versus Simultaneous Bilateral Knee Arthroplasty

  NCT03564730· Orthopaedic Innovation Centre· Source

• Recruiting

  American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

  NCT02674100· University of Louisville· Source

• Active, not recruiting

  A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

  NCT03127631· McMaster University· Source

• Active, not recruiting

  Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

  NCT02488967· Phase 3· NRG Oncology· Source

• Active, not recruiting

  Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

  NCT01886872· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

  NCT01522976· Phase 2· National Cancer Institute (NCI)· Source

• Active, not recruiting

  A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

  NCT01396408· Phase 2· Canadian Cancer Trials Group· Source

• Active, not recruiting

  Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

  NCT01368588· Phase 3· Radiation Therapy Oncology Group· Source

• Active, not recruiting

  Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

  NCT01274338· Phase 3· National Cancer Institute (NCI)· Source

• Active, not recruiting

  Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery

  NCT01220583· Phase 2· Radiation Therapy Oncology Group· Source

• Active, not recruiting

  RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

  NCT00956007· Phase 3· Radiation Therapy Oncology Group· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• Lung cancer2 recruiting
• Pancreatic cancer2 recruiting
• Parkinson disease2 recruiting
• Asthma1 recruiting
• Brain aneurysm1 recruiting
• Endometrial cancer1 recruiting
• Epilepsy1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Head and neck cancer1 recruiting
• High blood pressure1 recruiting
• Lewy body dementia1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple system atrophy1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Type 1 diabetes1 recruiting

Closed trials

• Completed

  Petit Cactus Study

  NCT07380802· McGill University· Source

• Completed

  Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

  NCT06667414· Hoffmann-La Roche· Source

• Completed

  A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

  NCT05785832· Tandem Diabetes Care, Inc.· Source

• Recruiting

  A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

  NCT04951622· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

  NCT03892096· Cadex Genomics· Source

• Completed

  Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

  NCT03734029· Phase 3· Daiichi Sankyo· Source

• Completed

  High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib

  NCT02551068· University of British Columbia· Source

• Completed

  A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

  NCT02398656· Phase 3· University of Calgary· Source

• Completed

  Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

  NCT02254278· Phase 2· NRG Oncology· Source

• Completed

  LOWER: Lomitapide Observational Worldwide Evaluation Registry

  NCT02135705· Amryt Pharma· Source

• Completed

  A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma

  NCT01650701· Phase 3· The Lymphoma Academic Research Organisation· Source

• Completed

  S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer

  NCT01224665· SWOG Cancer Research Network· Source

• Completed

  Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

  NCT00980954· Phase 3· Radiation Therapy Oncology Group· Source

• Completed

  Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

  NCT00936390· Phase 3· Radiation Therapy Oncology Group· Source

• Completed

  A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

  NCT00676715· Phase 2· Genentech, Inc.· Source

• Completed

  Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

  NCT00324805· Phase 3· National Cancer Institute (NCI)· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Alzheimer disease408 works · 1 trial
• Parkinson disease173 works · 3 trials
• Obesity172 works · 2 trials
• Stroke128 works · 1 trial
• HIV115 works · 0 trials
• Schizophrenia108 works · 1 trial
• Type 2 diabetes94 works · 2 trials
• Epilepsy88 works · 1 trial
• Tuberculosis79 works · 0 trials
• Multiple sclerosis71 works · 1 trial
• Ovarian cancer64 works · 1 trial
• Asthma60 works · 1 trial
• Melanoma59 works · 1 trial
• Atrial fibrillation53 works · 0 trials
• Bipolar disorder53 works · 0 trials
• Systemic sclerosis (scleroderma)50 works · 0 trials
• Depression47 works · 0 trials
• ALS (motor neurone disease)45 works · 0 trials
• Type 1 diabetes45 works · 2 trials
• Autism43 works · 0 trials
• Frontotemporal dementia42 works · 0 trials
• Cervical cancer41 works · 1 trial
• Endometrial cancer38 works · 1 trial
• COPD38 works · 0 trials
• Triple-negative breast cancer36 works · 1 trial
• Coronary artery disease35 works · 0 trials
• Ulcerative colitis35 works · 0 trials
• Crohn's disease33 works · 0 trials
• Sarcoma32 works · 0 trials
• Hepatitis C30 works · 1 trial